MIRM vs NVST · rev $336.1M vs P/E 56, rev $1.44B
Mirum Pharmaceuticals Inc (MIRM) versus Envista Holdings Corp (NVST) — a side-by-side from cached financials, not a winner call.
Mirum Pharmaceuticals Inc (MIRM) is a biotechnology company listed on NASDAQ.
Envista Holdings Corp (NVST) is a medical instruments & supplies company listed on US.
Latest reported MIRM revenue for 2026-06-30 was $336.1M. Net income was -$857.4M. MIRM currently screens at market cap $6.22B.
Latest reported NVST revenue for 2026-07-03 was $1.44B. Net income was $92.4M. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
MIRM currently screens at market cap $6.22B. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
Not investment advice. Open the MIRM and NVST stock pages for the full models.
Not investment advice.